3 papers5 findings
Dash diet
no changein humans1
Dash diet has no effect on parkinsonism in humans.
Humans4.6 yearsn = 706
MIND Diet Associated with Reduced Incidence and Delayed Progression of ParkinsonismA in Old Age
The journal of nutrition, health & aging1 Jan 2018
Hip fracture
upin humans1HR 1.42
Parkinsonism raises the risk of hip fracture in humans (HR 1.42, 95% CI 1.19-1.70).
Humansfollowing fall-related hospitalization2 yearsn = 88,140
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA8 Aug 2026
Mind diet
downin humans1HR 0.89
Mind diet lowers the risk of parkinsonism in humans (HR 0.89, 95% CI 0.83-0.96).
Humans4.6 yearsn = 706
MIND Diet Associated with Reduced Incidence and Delayed Progression of ParkinsonismA in Old Age
The journal of nutrition, health & aging1 Jan 2018
IL-6
upin humans1
Parkinsonism is associated with IL-6 in humans (28 (-3, 69)%).
Humansserum
Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism
Acta neurologica Scandinavica1 Jul 1999
TNF-alpha
upin humans1
Parkinsonism is associated with TNF-alpha in humans.
Humansin parkinsonians with abnormal postural and psychomotor responsesserum
Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism
Acta neurologica Scandinavica1 Jul 1999
California Pacific Medical Center Research Institute
1 trialPhase 42,721 people
Corporal Michael J. Crescenz VA Medical Center
1 trialPhase 410 people
1 trial50 people
In mouse midbrain and cultured human neurons, alpha-synuclein pathology led to shorter, more saturated lipid chains, an effect largely reversed in mice by intermittent…In mouse midbrain and cultured human neurons, alpha-synuclein pathology led to shorter, more saturated lipid chains, an effect largely reversed in mice by intermittent fasting.
In mice with severe mitochondrial disease, a two-drug treatment extended median lifespan from 62 days to 158 days.In mice with severe mitochondrial disease, a two-drug treatment extended median lifespan from 62 days to 158 days.
In a 52-week randomised trial, disease rating scores rose by 2.45 points with the supplement compared with a 0.27-point fall with placebo.In a 52-week randomised trial, disease rating scores rose by 2.45 points with the supplement compared with a 0.27-point fall with placebo.
In more than 26,000 US adults, people in the highest quarter of relative fat mass had 2.71 times the odds of Parkinson's disease.In more than 26,000 US adults, people in the highest quarter of relative fat mass had 2.71 times the odds of Parkinson's disease.
Rates of dementia and Parkinson's disease were lower after surgery, with hazard ratios of 0.48 and 0.70 compared with matched people without surgery.Rates of dementia and Parkinson's disease were lower after surgery, with hazard ratios of 0.48 and 0.70 compared with matched people without surgery.
In an observational study, 13.8% of older adults with normal cognitive test scores had memory or thinking concerns documented in their health records.In an observational study, 13.8% of older adults with normal cognitive test scores had memory or thinking concerns documented in their health records.